PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver disease |
| Symptom | C0004153|atherosclerosis |
| Sentences | 11 |
| PubMedID- 22359630 | Objectives: nonalcoholic fatty liver disease (nafld) is associated with advanced atherosclerosis and a higher risk of cardiovascular disease. |
| PubMedID- 22748277 | Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in asian indians. |
| PubMedID- 25463079 | Objective: non-alcoholic fatty liver disease (nafld) is associated with atherosclerosis and reduced vascular compliance. |
| PubMedID- 24381427 | A study of carotid atherosclerosis in patients with non-alcoholic fatty liver disease. |
| PubMedID- 22676459 | Background: insulin resistance (ir) is the major driving force behind development and progression of atherosclerosis in patients with nonalcoholic fatty liver disease (nafld). |
| PubMedID- 23626730 | Background: non-alcoholic fatty liver disease (nafld) is associated with cardiovascular atherosclerosis independent of classical risk factors. |
| PubMedID- 24069270 | Pnpla3 gg genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease. |
| PubMedID- 22814750 | Nonalcoholic fatty liver disease is associated with atherosclerosis in middle-aged and elderly chinese. |
| PubMedID- 23185655 | Despite several previous studies demonstrated the association between nafld and carotid imt and/or carotid plaque, no general consensus exists on the systematic screening of carotid atherosclerosis in patients with fatty liver disease. |
| PubMedID- 23085576 | Evaluation of early atherosclerosis markers in patients with nonalcoholic fatty liver disease. |
| PubMedID- 24794207 | Adiponectin has recently been considered as a possible link between liver dysfunction and atherosclerosis in patients with nonalcoholic fatty liver disease (nafld). |
Page: 1